- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06052319
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population (IPACE-CVD)
April 23, 2024 updated by: Janssen Scientific Affairs, LLC
A Pilot Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease/ Peripheral Artery Disease (CAD/PAD) Population
The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Study Contact
- Phone Number: 844-434-4210
- Email: Participate-In-This-Study@its.jnj.com
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of COlorado Anschutz Medical Campus
-
-
Florida
-
Jacksonville, Florida, United States, 32216
- Recruiting
- HCA Florida Memorial Hospital
-
Jacksonville, Florida, United States, 33209
- Recruiting
- University of Florida Health Jacksonville
-
-
Kansas
-
Overland Park, Kansas, United States, 662111
- Recruiting
- The Kansas City Heart Rhythm Institute
-
-
Texas
-
Houston, Texas, United States, 77004
- Recruiting
- HCA Houston Healthcare Medical Center
-
McAllen, Texas, United States, 78503
- Recruiting
- Rio Grande Regional Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population will include participants ages 40-90 diagnosed with coronary artery disease (CAD) or peripheral artery disease (PAD) or both.
Description
Inclusion Criteria:
- Must have a diagnosis of CAD and or PAD, who are on therapy or about to initiate therapy
- Own an iPhone or Android mobile device
- Have an active email account
- Must sign a participation agreement or informed consent form (ICF) allowing data collection in accordance with local requirements
- Willing to download and use Care4Today (C4T) CAD-PAD application (app)
Exclusion Criteria:
- Any cardiovascular conditions (for example, recent stroke, high bleeding risk, severe heart failure) or non-cardiovascular condition deemed as poor prognosis by the investigator and which may percent a patient from completing the study
- Unable to read or write the language used for the C4T (English, or Spanish if Spanish version is available)
- Visual or hearing impairment or mental disability that would preclude independent app use
- Patients currently using the C4T app prior to the signing of ICF
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Participants with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) or Both
Participants with CAD or PAD or both will be directed to download the Care4Today® (C4T) Connect CAD-PAD mobile application on iPhone or Android device to assess engagement and usefulness of C4T in disease management for 3 months.
No study drug and other treatment(s) will be provided as a part of this study.
All aspects of treatment and clinical management of participants will continue to be in accordance with local clinical practice and applicable local regulations, and at the discretion of the participating physician.
|
Participants will not receive any drug intervention in this study.
Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months.
The study will assess participant engagement and usefulness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants Who use the Care4Today (C4T) Coronary Artery Disease-Peripheral Artery Disease (CAD-PAD) Application for at Least 10 Weeks During the 3-Month Study Period
Time Frame: Up to 3 months
|
Percentage of participants (of those who onboarded the C4T CAD-PAD app) who use CAD-PAD the application for at least 10 weeks during the 3-month study period will be reported.
The weekly app use is defined as using at least one component of the app once a week.
|
Up to 3 months
|
Percentage of Engaged Participants who Complete End of Study Survey with Satisfaction Response Score of Greater Than or Equal to (>=) 2 for at Least 3 Questions
Time Frame: Up to 3 months
|
Percentage of engaged participants who complete end of study survey with satisfaction response score of >= 2 for at least 3 questions (out of 6 total questions) will be reported.
Satisfaction survey consists of six questions in the end of study - each with 5 possible responses on a likert scale (1-5).
The lowest possible response to any question is 1 =disagree and the highest possible response to any question is 5 = agree.
Higher response on this scale represents more agreement or satisfaction.
|
Up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Janssen Scientific Affairs, LLC Clinical Trial, Janssen Scientific Affairs, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 29, 2023
Primary Completion (Estimated)
July 15, 2024
Study Completion (Estimated)
July 15, 2024
Study Registration Dates
First Submitted
September 18, 2023
First Submitted That Met QC Criteria
September 18, 2023
First Posted (Actual)
September 25, 2023
Study Record Updates
Last Update Posted (Actual)
April 24, 2024
Last Update Submitted That Met QC Criteria
April 23, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOPRODPEA0001 (Other Identifier: Janssen Scientific Affairs, LLC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease (CAD)
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
GE HealthcarePharmaceutical Product Development, LLCCompletedCoronary Artery Disease (CAD)United States, Germany, Switzerland, Canada, Netherlands, France, Finland
-
Columbia UniversityTerminatedCoronary Artery Disease (CAD)United States
-
The Medicines CompanyCompletedCoronary Artery Disease (CAD)United States
-
Korea UniversityTerminatedCoronary Artery Disease (CAD)Korea, Republic of
-
B. Braun Melsungen AGCharite University, Berlin, GermanyCompleted
-
CathWorks Ltd.CompletedCAD - Coronary Artery DiseaseIsrael
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Disease (CAD)United States
-
Jun LiShanghai Hutchison Pharmaceuticals LimitedUnknownCoronary Artery Disease(CAD)
-
Jun LiChina Academy of Chinese Medical SciencesUnknownCoronary Artery Disease(CAD)
Clinical Trials on Care4Today® Connect CAD-PAD Mobile Application
-
Janssen Scientific Affairs, LLCCompletedAtrial FibrillationUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of Wisconsin Center for Tobacco...CompletedSmoking | Smoking CessationUnited States
-
University of California, San DiegoJanssen Research & Development, LLCCompleted
-
Ad scientiamRecruitingMultiple SclerosisItaly, France, Canada, United States, Denmark, Germany, Spain
-
Umeå UniversitySwedish Council for Working Life and Social Research; Jämtland County Council... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation in ChildrenCompletedPediatric Heart Transplantation | Pediatric Heart Transplant Recipients | Pediatric Cardiac TransplantationUnited States
-
Avation Medical, Inc.Enrolling by invitationUrinary Incontinence | Urinary Urge IncontinenceUnited States
-
Wake Forest University Health SciencesAtrium Health Levine Cancer InstituteCompletedColorectal SurgeryUnited States